ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma

Cao, Kui; Ling, Xiaodong; Jiang, Xiangyu; Ma, Jianqun*; Zhu, Jinhong*哈尔滨医科大学
Respiratory Research2022-11-10DOI: 10.1186/s12931-022-02226-z
3被引6阅读
引用收藏
分享

摘要

Background Ubiquitin-conjugating enzyme E2 T (UBE2T) is a potential oncogene. However, Pan-cancer analyses of the functional, prognostic and predictive implications of this gene are lacking. Methods We first analyzed UBE2T across 33 tumor types in The Cancer Genome Atlas (TCGA) project. We investigated the expression level of UBE2T and its effect on prognosis using the TCGA database. The correlation between UBE2T and cell cycle in pan-cancer was investigated using the single-cell sequencing data in Cancer Single-cell State Atlas (CancerSEA) database. The Weighted Gene Co-expression Network analysis (WGCNA), Univariate Cox and Least absolute shrinkage and selection operator (LASSO) Cox regression models, and receiver operating characteristic (ROC) were applied to assess the prognostic impact of UBE2T-related cell cycle genes (UrCCGs). Furthermore, the consensus clustering (CC) method was adopted to divide TCGA-lung adenocarcinoma (LUAD) patients into subgroups based on UrCCGs. Prognosis, molecular characteristics, and the immune panorama of subgroups were analyzed using Single-sample Gene Set Enrichment Analysis (ssGSEA). Results derived from TCGA-LUAD patients were validated in International Cancer Genome Consortium (ICGC)-LUAD data. Results UBE2T is highly expressed and is a prognostic risk factor in most tumors. CancerSEA database analysis revealed that UBE2T was positively associated with the cell cycle in various cancers(r > 0.60, p < 0.001). The risk signature of UrCCGs can reliably predict the prognosis of LUAD (AUC(1 year) = 0.720, AUC(3 year) = 0.700, AUC(5 year) = 0.630). The CC method classified the TCGA-LUAD cohort into 4 UrCCG subtypes (G1-G4). Kaplan-Meier survival analysis demonstrated that G2 and G4 subtypes had worse survival than G3 (Log-rank test P-TCGA training set < 0.001, P-ICGC validation set < 0.001). A comprehensive analysis of immune infiltrates, immune checkpoints, and immunogenic cell death modulators unveiled different immune landscapes for the four subtypes. High immunophenoscore in G3 and G4 tumors suggested that these two subtypes were immunologically "hot," tending to respond to immunotherapy compared to G2 subtypes (p < 0.001). Conclusions UBE2T is a critical oncogene in many cancers. Moreover, UrCCG classified the LUAD cohort into four subgroups with significantly different survival, molecular features, immune infiltrates, and immunotherapy responses. UBE2T may be a therapeutic target and predictor of prognosis and immunotherapy sensitivity.

学科与关键词

关键词
Pan-cancerUBE2TRisk signatureConsensus clusteringTumor immune infiltrationLUAD
相关
加载中…
  • Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target
    Huang, Guang-zhao; Chen, Ze-qun; Wu, Juan; Shao, Ting-ru; Zou, Chen; Ai, Yi-long*; Lv, Xiao-zhi*Journal of Immunology Research, 2021, 2021: 9250207.被引 6
  • System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma
    Huang, Renlun; Guo, Lang; Chen, Chiwei; Xiang, Yuyang; Li, Guohao; Zheng, Jieyan; Wu, Yanping; Yuan, Xiu; Zhou, Jianfu; Gao, Wenxi*; Xiang, Songtao*PLoS One, 2023, 18(8): e0289418.被引 1
  • Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
    Liu, Mengfeng; Xiao, Qifan; Yu, Xiran; Zhao, Yujie; Qu, Changfa*Frontiers in Pharmacology, 2022, 13: 1081244.
查看全部 →

发表信息

论文状态
公开发表
期刊
Respiratory Research
发表日期
2022-11-10
卷期
第 23 卷, 第 1 期
页码
306
DOI
10.1186/s12931-022-02226-z
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of China [82172786]; Haiyan Foundation of Harbin Medical University Cancer Hospital [JJZD2020-01]; National Cancer Center Climbing Fund of China [NCC201908B06]; Natural Science Foundation of Heilongjiang Province [LH2021H077]

作者

  • C

    Cao, Kui (第一作者)

    harbin med univ

  • L

    Ling, Xiaodong

    harbin med univ

查看全部 5 位作者收起作者
  • J

    Jiang, Xiangyu

    harbin med univ

  • M

    Ma, Jianqun (通讯)

    harbin med univ

  • Z

    Zhu, Jinhong (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417